Mini tumors in a dish could pick the right drug for stubborn cancers
NCT ID NCT05267912
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether growing a patient's tumor cells in the lab (as 3D 'organoids') can help doctors pick the best drug for advanced cancers that have stopped responding to standard treatments. About 152 adults with colorectal or pancreatic cancer will have a biopsy to create these organoids, which are then exposed to a panel of drugs to see which ones work. The goal is to see if this personalized approach is feasible and can improve how long patients live without their cancer growing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tumor organoid-based chemogram (lab test on biopsy sample)
- What this could lead to
- If successful, this could help doctors choose more effective drugs for patients with advanced cancers that have stopped responding to standard treatments.
- What could go wrong
- This is an early feasibility study, not a treatment trial. The organoid test may not always predict real patient responses, and results may not lead to better outcomes for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Poitiers
NOT_YET_RECRUITINGPoitiers, France, 86000, France
-
Centre Eugène Marquis
RECRUITINGRennes, France, 35000, France
-
Centre Léon Bérard
ACTIVE_NOT_RECRUITINGLyon, France, 69008, France
-
Centre Oscar Lambret
RECRUITINGLille, France, 59000, France
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
HIA Bégin
RECRUITINGSaint-Mandé, France, 94160, France
-
Hôpital Pitié-Salpêtrière
RECRUITINGParis, France, 75013, France
-
Hôpital Saint Louis
RECRUITINGParis, France, 75010, France
-
Hôpital St Antoine
RECRUITINGParis, France, 75571, France
-
Institut Bergonié
RECRUITINGBordeaux, France, 33000, France
-
Institut Godinot
RECRUITINGReims, France, 51726, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- A sound wave that could expose hidden pancreatic cancer?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?